help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KUDOH, S.
Right arrow Articles by ANDO, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KUDOH, S.
Right arrow Articles by ANDO, M.

Am. J. Respir. Crit. Care Med., Volume 157, Number 6, June 1998, 1829-1832

Improvement of Survival in Patients with Diffuse Panbronchiolitis Treated with Low-dose Erythromycin

SHOJI KUDOH, ARATA AZUMA, MASAHIKO YAMAMOTO, TAKATERU IZUMI, and MASAYUKI ANDO

Fourth Department of Internal Medicine, Nippon Medical School, Tokyo; Medical School, Nagoya City University, Nagoya; Chest Disease Research Institute, Kyoto University, Kyoto; First Department of Internal Medicine, Kumamoto University, Kamamoto; and Research Group of Diffuse Pulmonary Disease Committee Organized by Ministry of Health and Welfare of Japan, Tokyo, Japan

Diffuse panbronchiolitis (DPB) is a chronic inflammatory disease of the airways with a high rate of mortality despite treatment with a combination of antibiotics and the use of supportive therapy such as oxygen administration. Low-dose erythromycin therapy (EM) (400 to 600 mg/d) has been found to improve the survival of patients with DPB, and most patients with DPB in Japan have been treated with this erythromycin regime since 1984. The purpose of this study was to evaluate the effects of treatment with erythromycin on the survival rate of patients with DPB in Japan. We compared the survival rates of 498 patients with DPB after dividing them into three groups according to the date of their first medical examination (Group a: 1970-1979, Group b: 1980-1984, Group c: 1985-1990). DPB had been diagnosed in these patients using the criteria of the Ministry of the Health and Welfare Diffuse Lung Disease Committee (MHW-DLDC), which includes chronic productive cough, shortness of breath, presence of roentgenologically smoldering symmetrical granular shadows in the middle and lower lung fields, limitation of airflow without decrease in DLCO, elevated serum cold hemagglutinin titers, and/or narrowing bronchiolus with infiltration of lymphocytes and foamy alveolar macrophages. These patients were registered in the DPB research group of the Ministry of Health and Welfare (MHW). Survival rates were statistically compared using the generalized-Wilcoxon test. The survival rate of Group c was significantly higher than that of Groups a (p < 0.0001) and b (p < 0.0001). In Group c, eight of 87 patients died; five died in the EM nontreated subgroup (n = 24), and three died in the EM-treated subgroup (n = 63). There was a significant difference in the survival rates between the two subgroups in Group c (p < 0.001). Treatment with EM was associated with a significant improvement in the rate of survival of patients with DPB. The efficacy of EM treatment increased the survival rate of patients with DPB, which was more significant in the older than in the younger patients.




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
M. Bosnar, B. Bosnjak, S. Cuzic, B. Hrvacic, N. Marjanovic, I. Glojnaric, O. Culic, M. J. Parnham, and V. E. Haber
Azithromycin and Clarithromycin Inhibit Lipopolysaccharide-Induced Murine Pulmonary Neutrophilia Mainly through Effects on Macrophage-Derived Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-1{beta}
J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 104 - 113.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R. Stamatiou, E. Paraskeva, K. Boukas, K. I. Gourgoulianis, P-A. Molyvdas, and A. A. Hatziefthimiou
Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells
Eur. Respir. J., September 1, 2009; 34(3): 721 - 730.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
Y. Nakanishi, D. Kobayashi, Y. Asano, T. Sakurai, M. Kashimura, S. Okuyama, Y. Yoneda, S. D. Shapiro, and K. Takayama
Clarithromycin Prevents Smoke-induced Emphysema in Mice
Am. J. Respir. Crit. Care Med., February 15, 2009; 179(4): 271 - 278.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. A. J. Crosbie and M. A. Woodhead
Long-term macrolide therapy in chronic inflammatory airway diseases
Eur. Respir. J., January 1, 2009; 33(1): 171 - 181.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
H. Ishimoto, H. Mukae, N. Sakamoto, M. Amenomori, T. Kitazaki, Y. Imamura, H. Fujita, H. Ishii, S. Nakayama, K. Yanagihara, et al.
Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin
J. Antimicrob. Chemother., January 1, 2009; 63(1): 109 - 114.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. A. R. Seemungal, T. M. A. Wilkinson, J. R. Hurst, W. R. Perera, R. J. Sapsford, and J. A. Wedzicha
Long-term Erythromycin Therapy Is Associated with Decreased Chronic Obstructive Pulmonary Disease Exacerbations
Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1139 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
T. Tsuda, C. Ishikawa, H. Konishi, Y. Hayashi, N. Nakagawa, M. Matsuki, H. Mizutani, and K. Yamanishi
Effect of 14-Membered-Ring Macrolides on Production of Interleukin-8 Mediated by Protease-Activated Receptor 2 in Human Keratinocytes
Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1538 - 1541.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
N. Hoffmann, B. Lee, M. Hentzer, T. B. Rasmussen, Z. Song, H. K. Johansen, M. Givskov, and N. Hoiby
Azithromycin Blocks Quorum Sensing and Alginate Polymer Formation and Increases the Sensitivity to Serum and Stationary-Growth-Phase Killing of Pseudomonas aeruginosa and Attenuates Chronic P. aeruginosa Lung Infection in Cftr / Mice
Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3677 - 3687.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. K. Brown
Chronic Cough Due to Nonbronchiectatic Suppurative Airway Disease (Bronchiolitis): ACCP Evidence-Based Clinical Practice Guidelines
Chest, January 1, 2006; 129(1_suppl): 132S - 137S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. Ishizawa, T. Suzuki, M. Yamaya, Y. X. Jia, S. Kobayashi, S. Ida, H. Kubo, K. Sekizawa, and H. Sasaki
Erythromycin increases bactericidal activity of surface liquid in human airway epithelial cells
Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L565 - L573.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
A Bush
How has research in the last five years changed my clinical practice?
Arch. Dis. Child., August 1, 2005; 90(8): 832 - 836.
[Abstract] [Full Text] [PDF]

Home page
 Chronic Respiratory DiseaseHome page
S C Bell, S L Senini, and J G McCormack
Macrolides in cystic fibrosis
Chronic Respiratory Disease, April 1, 2005; 2(2): 85 - 98.
[Abstract] [PDF]

Home page
 JAMAHome page
L. Saiman, B. C. Marshall, N. Mayer-Hamblett, J. L. Burns, A. L. Quittner, D. A. Cibene, S. Coquillette, A. Y. Fieberg, F. J. Accurso, and P. W. Campbell III
Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa: A Randomized Controlled Trial
JAMA, October 1, 2003; 290(13): 1749 - 1756.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. Kaneko, K. Yanagihara, M. Seki, M. Kuroki, Y. Miyazaki, Y. Hirakata, H. Mukae, K. Tomono, J.-i. Kadota, and S. Kohno
Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis
Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L847 - L853.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
T. Yamaryo, K. Oishi, H. Yoshimine, Y. Tsuchihashi, K. Matsushima, and T. Nagatake
Fourteen-Member Macrolides Promote the Phosphatidylserine Receptor-Dependent Phagocytosis of Apoptotic Neutrophils by Alveolar Macrophages
Antimicrob. Agents Chemother., January 1, 2003; 47(1): 48 - 53.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
T. Kobayashi, K. Tateda, T. Matsumoto, S. Miyazaki, A. Watanabe, T. Nukiwa, and K. Yamaguchi
Macrolide-treated Pseudomonas aeruginosa induces paradoxical host responses in the lungs of mice and a high mortality rate
J. Antimicrob. Chemother., July 1, 2002; 50(1): 59 - 66.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
T. Kikuchi, K. Hagiwara, Y. Honda, K. Gomi, T. Kobayashi, H. Takahashi, Y. Tokue, A. Watanabe, and T. Nukiwa
Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-{kappa}B transcription factors
J. Antimicrob. Chemother., May 1, 2002; 49(5): 745 - 755.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
K. Yanagihara, K. Tomono, Y. Imamura, Y. Kaneko, M. Kuroki, T. Sawai, Y. Miyazaki, Y. Hirakata, H. Mukae, J.-I. Kadota, et al.
Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model
J. Antimicrob. Chemother., May 1, 2002; 49(5): 867 - 870.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
Y. Tsuchihashi, K. Oishi, H. Yoshimine, S. Suzuki, A. Kumatori, T. Sunazuka, S. Omura, K. Matsushima, and T. Nagatake
Fourteen-Member Macrolides Suppress Interleukin-8 Production but Do Not Promote Apoptosis of Activated Neutrophils
Antimicrob. Agents Chemother., April 1, 2002; 46(4): 1101 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
L. Saiman, Y. Chen, P. S. Gabriel, and C. Knirsch
Synergistic Activities of Macrolide Antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans Isolated from Patients with Cystic Fibrosis
Antimicrob. Agents Chemother., April 1, 2002; 46(4): 1105 - 1107.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
R. Nau and H. Eiffert
Modulation of Release of Proinflammatory Bacterial Compounds by Antibacterials: Potential Impact on Course of Inflammation and Outcome in Sepsis and Meningitis
Clin. Microbiol. Rev., January 1, 2002; 15(1): 95 - 110.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. Gorrini, A. Lupi, S. Viglio, F. Pamparana, G. Cetta, P. Iadarola, J. C. Powers, and M. Luisetti
Inhibition of Human Neutrophil Elastase by Erythromycin and Flurythromycin, Two Macrolide Antibiotics
Am. J. Respir. Cell Mol. Biol., October 1, 2001; 25(4): 492 - 499.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
T. Suzuki, M. Yanai, M. Yamaya, T. Satoh-Nakagawa, K. Sekizawa, S. Ishida, and H. Sasaki
Erythromycin and Common Cold in COPD
Chest, September 1, 2001; 120(3): 730 - 733.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. Yamada, T. Igarashi, E. Itoh, H. Tanaka, K. Sekine, and S. Abe
Centrilobular Nodules Correlate With Air Trapping in Diffuse Panbronchiolitis During Erythromycin Therapy
Chest, July 1, 2001; 120(1): 198 - 202.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. Azuma, Y. Li, J. Usuki, A. Aoyama, T. Enomoto, and S. Kudoh
Fourteen-Membered Ring Macrolides Inhibit Vascular Cell Adhesion Molecule-1 Messenger RNA Induction Preventing Neutrophil-Induced Lung Injury and Fibrosis in Bleomycin-Challenged Mice
Chest, July 1, 2001; 120 (2009): 20S - 22S.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. NAKANO, H. IDE, M. IMADA, S. OSANAI, T. TAKAHASHI, K. KIKUCHI, and J. IWAMOTO
Reduced Nasal Nitric Oxide in Diffuse Panbronchiolitis
Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2218 - 2220.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. BUSH, H. TIDDENS, and M. SILVERMAN
Clinical Implications of Inflammation in Young Children
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): S11 - 14.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. KEICHO, K. TOKUNAGA, K. NAKATA, Y. TAGUCHI, A. AZUMA, M. BANNAI, M. EMI, N. OHISHI, Y. YAZAKI, and S. KUDOH
Contribution of HLA Genes to Genetic Predisposition in Diffuse Panbronchiolitis
Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 846 - 850.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society 		  SOTA, FL